Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupert Lanzenberger

Showing results (251-260 of 267) with videos related to

Pageof 27
Sort By:
Neuroimage|March 16, 2023
Whole-body metabolic connectivity framework with functional PETMurray Bruce Reed, Magdalena Ponce de León, Chrysoula Vraka, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|June 18, 2016
Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and geneticsAndrea Schmitt, Dan Rujescu, Micha Gawlik, et al.
Psychoneuroendocrinology|August 20, 2021
High-dose testosterone treatment reduces monoamine oxidase A levels in the human brain: A preliminary reportGeorg S Kranz, Marie Spies, Chrysoula Vraka, et al.
Frontiers in Human Neuroscience|September 12, 2019
Predicting Ventral Striatal Activation During Reward Anticipation From Functional Connectivity at RestAsako Mori, Manfred Klöbl, Go Okada, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 14, 2026
Continuous infusion [<sup>11</sup>C]-(+)-PHNO PET for measuring dopamine D<sub>2/3</sub> receptor availability and amphetamine effects across the brain: Feasibility and test-retest reliabilityIrena Dajic, Ulrich Sauerzopf, Ana Weidenauer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 8, 2021
First-in-Humans Brain PET Imaging of the GluN2B-Containing <i>N</i>-methyl-d-aspartate Receptor with (<i>R</i>)-<sup>11</sup>C-Me-NB1Lucas Rischka, Chrysoula Vraka, Verena Pichler, et al.
Journal of Affective Disorders|June 23, 2025
Phenotyping extracellular vesicles and their serotonin transporter cargo in major depressive disorderŁukasz Zadka, Benjamin Eggerstorfer, Igor Buzalewicz, et al.
Cerebral Cortex (New York, N.Y. : 1991)|October 26, 2018
Parcellation of the Human Cerebral Cortex Based on Molecular Targets in the Serotonin System Quantified by Positron Emission Tomography In vivoGregory M James, Gregor Gryglewski, Thomas Vanicek, et al.
EJNMMI Research|August 26, 2022
Biodistribution and dosimetry of the GluN2B-specific NMDA receptor PET radioligand (R)-[<sup>11</sup>C]Me-NB1Lucas Rischka, Matej Murgaš, Verena Pichler, et al.
Translational Psychiatry|September 23, 2018
Brain monoamine oxidase A in seasonal affective disorder and treatment with bright light therapyMarie Spies, Gregory M James, Chrysoula Vraka, et al.
Pageof 27

Showing results (251-260 of 267) with videos related to

Sort By:
Pageof 27
Neuroimage|March 16, 2023
Whole-body metabolic connectivity framework with functional PETMurray Bruce Reed, Magdalena Ponce de León, Chrysoula Vraka, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|June 18, 2016
Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and geneticsAndrea Schmitt, Dan Rujescu, Micha Gawlik, et al.
Psychoneuroendocrinology|August 20, 2021
High-dose testosterone treatment reduces monoamine oxidase A levels in the human brain: A preliminary reportGeorg S Kranz, Marie Spies, Chrysoula Vraka, et al.
Frontiers in Human Neuroscience|September 12, 2019
Predicting Ventral Striatal Activation During Reward Anticipation From Functional Connectivity at RestAsako Mori, Manfred Klöbl, Go Okada, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 14, 2026
Continuous infusion [<sup>11</sup>C]-(+)-PHNO PET for measuring dopamine D<sub>2/3</sub> receptor availability and amphetamine effects across the brain: Feasibility and test-retest reliabilityIrena Dajic, Ulrich Sauerzopf, Ana Weidenauer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 8, 2021
First-in-Humans Brain PET Imaging of the GluN2B-Containing <i>N</i>-methyl-d-aspartate Receptor with (<i>R</i>)-<sup>11</sup>C-Me-NB1Lucas Rischka, Chrysoula Vraka, Verena Pichler, et al.
Journal of Affective Disorders|June 23, 2025
Phenotyping extracellular vesicles and their serotonin transporter cargo in major depressive disorderŁukasz Zadka, Benjamin Eggerstorfer, Igor Buzalewicz, et al.
Cerebral Cortex (New York, N.Y. : 1991)|October 26, 2018
Parcellation of the Human Cerebral Cortex Based on Molecular Targets in the Serotonin System Quantified by Positron Emission Tomography In vivoGregory M James, Gregor Gryglewski, Thomas Vanicek, et al.
EJNMMI Research|August 26, 2022
Biodistribution and dosimetry of the GluN2B-specific NMDA receptor PET radioligand (R)-[<sup>11</sup>C]Me-NB1Lucas Rischka, Matej Murgaš, Verena Pichler, et al.
Translational Psychiatry|September 23, 2018
Brain monoamine oxidase A in seasonal affective disorder and treatment with bright light therapyMarie Spies, Gregory M James, Chrysoula Vraka, et al.
Pageof 27